Medical chewing gum comprising cannabinoid

A medical chewing gum comprising gum base polymers and one or more cannabinoids as an active pharmaceutical ingredient, wherein

• the gum base polymers constitute more than 50% by weight of the total content of gum base ingredients,
• the total content of gum base ingredients selected from the list consisting of polyterpene resins, resins based on gum rosin, wood rosin and tall oil resin is less than 5% by weight of the chewing gum, and
• the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer,
• wherein the chewing gum is a compressed chewing gum comprising granules with a content of gum base and extragranular chewing gum ingredients.

A medical chewing gum comprising gum base with a content of gum base polymers and one or more cannabinoids as an active pharmaceutical ingredient, wherein

• the gum base comprises 15-45% by weight of polyvinyl acetate and 10-30% by weight of vinyl laurate-vinyl acetate copolymer,
• the total content of gum base ingredients selected from the list consisting of polyterpene resins, resins based on gum rosin, wood rosin and tall oil resin is less than 5% by weight of the chewing gum, and
• the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer,
• wherein the chewing gum is a compressed chewing gum comprising granules with a content of gum base and extragranular chewing gum ingredients.